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in this population compared to what the normal distribu-
tion would be leads us to propose the following potential
mechanisms for development of CHD in this population:
local environmental factors or epigenetic factors influ-
encing gene expression differentially in the twin pairs;
reciprocal laterality signaling between twinned embryos
during early development; or placental vascular factors
that may contribute to severe valvar lesions leading to
hypoplasia of the right or left heart or milder forms of
valve disease in the setting of TTTS.
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OBJECTIVES: Left ventricular cardiac output is de-
creased in fetuses with congenital diaphragmatic hernia
(CDH). Our aim was to assess whether this alters cerebral
perfusion or growth in utero. METHODS: Fetal head
circumference, biparietal diameter, lung-to-head ratio
and middle cerebral artery (MCA) Doppler flow patterns
were assessed with ultrasound in 103 fetuses with prena-
tally diagnosed CDH. Total fetal lung volume and cere-
bral volume were measured using magnetic resonance
imaging. Values were transformed to gestational age in-
dependent scores (multiples of the median; MoM) and
compared with controls. Subanalyses were made accord-
ing to whether the CDH was left (n=86) or right sided
(n=17) and to whether it was isolated (n= 86) or asso-
ciated with other anomalies (n=17). RESULTS: Mid-
dle cerebral artery flow velocity was significantly lower
in CDH than in healthy fetuses (0.79 ± 0.19 MoM; p
< 0.0001) but MCA pulsatility index was unchanged
(0.99 ± 0.25 MoM; p = 0.79). Cranial biometry and
cerebral volume in CDH fetuses fall in the normal range.
Gestational age adjusted lung area was correlated with
MCA peak systolic velocity which was in turn corre-
lated with brain volume. CONCLUSION: Fetal cerebral
perfusion is decreased in CDH yet cranial and cerebral
growth are conserved. Further work will need to address
whether part of the neurologic impairment observed in
long-term survivors of CDH finds its origin in the prena-
tal period.
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OBJECTIVES: As a novel means of identifying patho-
physiologic changes in fetuses with common aneuploi-
dies, we characterized developmental gene expression
using cell-free mRNA in residual second trimester amni-
otic fluid (AF) supernatant samples. METHODS: RNA
was extracted from AF in fetuses with trisomy 21
[T21] (n=7), trisomy 18 [T18] (n=5), and euploid
controls (n=13). cDNA synthesis and biotin labeling
were performed prior to hybridization to Affymetrix
U133 plus 2.0 arrays. Initial analysis was done using
the Affymetrix Gene Chip Microarray Suite 5.0, fol-
lowed by comparative t-tests and Benjamini-Hochberg
adjustment. Differentially-expressed genes were fur-
ther examined using the Database for Annotation, Vi-
sualization, and Integrated Discovery (DAVID) and
Ingenuity R©Pathways Analysis. RESULTS: In T21 we
identified 414 differentially-expressed genes vs. euploid
controls. Only 5/414 genes identified mapped to chro-
mosome 21. In T18, only 7/356 differentially-expressed
genes were on chromosome 18. Heat map and functional
analyses of genes not on 18 or 21 showed consistent
patterns that were unique for each aneuploidy but dif-
fered significantly from euploidy. Only 6 differentially-
expressed transcripts were common to both aneuploidies.
T21 samples showed significant oxidative stress and dis-
ruption in ion transport, G-protein signaling, immune re-
sponse, and circulatory system function. T18 showed
significant disruption of both the endocrine system and
lipid metabolism. CONCLUSIONS: Residual AF sam-
ples provide a reproducible source of mRNA for genomic
analysis of aneuploid fetuses. Our results question the
conventional wisdom that the pathophysiology of aneu-
ploidy is due to a gene dosage effect, as the molecular
abnormalities observed here are predominantly produced
by genes on chromosomes other than 18 or 21. Path-
way analysis may provide new insights into each condi-
tion. For example, the down-regulation of the endocrine
system may explain why fetuses with T18 are growth-
restricted. This discovery-driven genomic approach us-
ing discarded material suggests new avenues to further
understand fetal abnormal development and may suggest
a personalized medicine approach to fetal therapy.
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